Sign In
Buy SMMT
$15.07
+0.210 (+1.41%)
At Close: Jun 03, 2026
Summit Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
07:30am, Tuesday, 06'th Jan 2026
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it will participate in and present at the 44th Annual J.P.
2 Stocks Up Over 600% in the Past 3 Years With More Room to Run
05:05pm, Tuesday, 09'th Dec 2025
Summit Therapeutics has an incredibly promising cancer candidate in the pipeline. Madrigal Pharmaceuticals made a breakthrough that could drive strong results for years to come.
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 05'th Dec 2025
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of
Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now?
01:05pm, Friday, 05'th Dec 2025
In a previous clinical trial, Summit's cancer drug ivonescimab showed it was more effective than Keytruda. The excitement propelled Summit's stock to a valuation that at one point reached $27 billion.
Summit Therapeutics Inc. (SMMT) Presents at Evercore 8th Annual Healthcare Conference Transcript
09:43pm, Wednesday, 03'rd Dec 2025
Summit Therapeutics Inc. (SMMT) Presents at Evercore 8th Annual Healthcare Conference Transcript
Don't Buy Summit Therapeutics Until This Big Thing Happen
04:44am, Wednesday, 03'rd Dec 2025
Summit Therapeutics plans to file for a key FDA approval by the end of this year. The drugmaker is betting that the FDA will change its mind on guidance already handed down.
Summit Therapeutics Inc. (SMMT) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
05:13pm, Tuesday, 02'nd Dec 2025
Summit Therapeutics Inc. (SMMT) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
2 Monster Stocks in the Making to Buy and Hold
07:00am, Tuesday, 02'nd Dec 2025
SoFi Technologies could become the dominant banking model in the future. Summit Therapeutics is developing a drug with incredible sales potential.
Contrasting Summit Therapeutics (NASDAQ:SMMT) & GelStat (OTCMKTS:GSAC)
02:14am, Tuesday, 02'nd Dec 2025
GelStat (OTCMKTS:GSAC - Get Free Report) and Summit Therapeutics (NASDAQ: SMMT - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based
Summit C-Suite Risks Success, Akeso Wins Either Way
07:27pm, Thursday, 20'th Nov 2025
Akeso stands out as a diversified Chinese biotech with strong licensing deals, a robust pipeline, and growing revenues from multiple approved therapies. Unlike SMMT, AKESF benefits from milestone paym
Summit: A Cautious Bet Backed By Anti-VEGF & Insider Buying
04:26am, Wednesday, 19'th Nov 2025
I'm rating Summit Therapeutics a 'cautious Buy' based on the promising dual-action lung cancer therapy Ivonescimab and significant insider buying. SMMT's Ivonescimab targets non-small cell lung cancer
Summit Therapeutics Inc. (SMMT) Presents at Jefferies London Healthcare Conference 2025 Transcript
12:38pm, Tuesday, 18'th Nov 2025
Summit Therapeutics Inc. ( SMMT ) Jefferies London Healthcare Conference 2025 November 18, 2025 10:30 AM EST Company Participants Dave Gancarz - Chief Business & Strategy Officer Manmeet Soni - COO, C
Summit Therapeutics Inc. (SMMT) Presents at UBS Global Healthcare Conference 2025 Transcript
04:11am, Tuesday, 11'th Nov 2025
Summit Therapeutics Inc. ( SMMT ) UBS Global Healthcare Conference 2025 November 10, 2025 3:30 PM EST Company Participants Dave Gancarz - Chief Business & Strategy Officer Manmeet Soni - COO, CFO & Di
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today noted that our partner, Akeso, Inc. (“Akeso,” HKEX Code: 9926.HK) pub
Summit Therapeutics to Present at Upcoming Investor Conferences
07:00am, Tuesday, 04'th Nov 2025
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it will participate in and present at four upcoming invest
